Research Article
BibTex RIS Cite

Neonatal Yoksunluk Sendromu (NYS) Sıklığı ve NYS’de Sistemik İnflamatuvar Yanıtın Değerlendirilmesi

Year 2019, Volume: 13 Issue: 3, 171 - 176, 24.05.2019

Cüneyt Tayman

https://doi.org/10.12956/tjpd.2018.357
Cited By: 2

Abstract

Amaç: Neonatal yoksunluk sendromu (NYS) görülme oranı giderek artan, ciddi bir sorundur. Türkiye’de gebelerde
yasadışı uyuşturucu kullanımı ve NYS oranı bilinmemektedir. Nötrofil lenfosit oranı (NLO) ve diğer akut faz belirteçleri
sistemik inflamatuvar yanıtın göstergeleridir. Çalışmada NYS sıklığını ve NYS’ lu yenidoğanlarda akut faz belirteçleri ve
NLO değerlerinin ölçümünü amaçladık.
Gereç ve Yöntemler: Hastanemizde doğum yapan ve madde bağımlılığı saptanan annelerin bebekleri çalışmaya dâhil
edildi. Ciddi sarılığı olmayan fototerapi için yatırılan infantlar kontrol grubu olarak değerlendirildi. Finnegan skoru ile
NYS bulguları değerlendirildi. Çalışma grubu hastaların kanlarında hemogram, C- reaktif protein (CRP), interlökin-6 (IL)
düzeyleri ölçüldü. NLO ve diğer belirteçleri gruplar arasında karşılaştırıldı.
Bulgular: Neonatal yoksunluk sendromu olgularının sayısının 3989 yatan hastada 16 adet olduğu (4.01/1000) saptandı.
Hematolojik parametreler değerlendirildiğinde NLO değerlerinin NYS grubunda anlamlı derecede yüksek olduğu (p<0.05)
bulundu. Her iki grubun platelet indekslerine bakıldığında ortalama platelet volümünün (MPV) değerinin NYS grubunda
anlamlı derecede yüksek olduğu izlendi (p<0.05). Neonatal yoksunluk sendromu bulguları nedeniyle ilaç tedavisi alan
hastalarda NLO değerlerinin daha yüksek olduğu bulundu (p<0.05).
Sonuç: Neonatal yoksunluk sendromu ciddi morbidite ve mortaliteye neden olan ve giderek artan toplumsal bir
problemdir. Bu ilaçlara intrauterin maruziyet yenidoğanda inflamatuvar süreci tetiklemektedir. NLO ve MPV değerlerinin
NYS’lu infantlarda yüksek olması inflamasyonu göstermektedir.

Keywords

Eroin Esrar Gebelik Neonatal yoksunluk sendromu

References

  • 1. Kocherlakota P. Neonatal Abstinence Syndrome. Pediatrics 2014;134:e547–61.
  • 2. Tolia VN, Patrick SW, Bennett MM. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med 2015; 372:2118-26.
  • 3. Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: A new standard. J Perinatol 2008; 28:597-603.
  • 4. WHO. Guidelines for identification and management of substance use and substance use disorders in pregnancy World Health Organization. 2014:224.
  • 5. Weaver MF. Perinatal addiction. In: Graham AW, Shultz TK (eds), Principles of Addiction Medicine, 3rd ed. American Society of Addiction Medicine, 2003:1231.
  • 6. Wong S, Ordean A, Kahan M; Maternal Fetal Medicine Committee; Family Physicians Advisory Committee; Medico-Legal Committee; Ad Hoc Reviewers; Special Contributors. Substance use in pregnancy. J Obstet Gynaecol Can 2011;33:367-84.
  • 7. Zahorec R. Ratio of neutrophil to lymphocyte counts- Rapid and simple parameter of systemic inflammation and stress n critically ill. Bratisl Lek Listy 2001; 102:5-14.
  • 8. Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A. C-Reactive Protein and substance use disorders in adolescence and early adulthood: A prospective analysis. Drug Alcohol Depend 2013;133:712–7.
  • 9. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: Assessment and management. Addict Dis 1975;2:141–58.
  • 10. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics 2012;129:540-60.
  • 11. Bagley SM, Wachman EM, Holland E, Brogly SB. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract 2014;9:19.
  • 12. Tetstall E, Liu AJ, An EI, Canalese J, Nanan R. Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: A rural and metropolitan comparison. Aust N Z J Obstet Gynaecol 2009;49: 279–84.
  • 13. Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S, Rough K, Mogun H, et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: Cohort study. BMJ 2017;358:3326.
  • 14. Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, et al. OCHNAS Consortium. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics 2014;134:e527-34.
  • 15. ACOG Committee on Practice Bulletins; Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111:1001–20.
  • 16. Shainker SA, Saia K, Lee-Parritz A. Opioid addiction in pregnancy. Obstet Gynecol Surv 2012;67:817–25.
  • 17. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn and young child. Int J Addict 1993;28:1341-91.
  • 18. Grossman MR, Berkwitt AK, Osborn RR. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics 2017;139:e20163360.
  • 19. Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D, Lindow SW. Neonatal outcome following maternal opiate use in late pregnancy. Int J Obstet Gynaecol 2001;74:241-6.
  • 20. Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol 2015;15:146.
  • 21. Yazar FM, Bakacak M, Emre A, Urfalıoglu A, Serin S, Cengiz E, et al. Predictive role of neutrophil-to-lymphocyte and plateletto- lymphocyte ratios for diagnosis of acute appendicitis during pregnancy. Kaohsiung J Med Sci 2015;31:591-6.
  • 22. Demir AK, Demirtas A, Kaya SU, Tastan I, Butun I, Sagcan M, et al. The relationship between the neutrophilelymphocyte ratio and disease activity in patients with ulcerative colitis. Kaohsiung J Med Sci 2015;31:585-90.
  • 23. Özkan N, Sonmez MB, Durmus P Tas, Gorgulu Y, Cınar R Kose, Vardar ME. Elevated neutrophil lymphocyte ratio in patients with substance use disorders. European Psychiatry 2017;41:S872-S873.
  • 24. Catal F, Tayman C, Tonbul A, Akça H, Kara S, Tatli MM, et al. Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants. Clin Lab 2014;60:1193-200.
  • 25. Witt CE, Rudd KE, Bhatraju P, Rivara FP, Hawes SE, Weiss NS. Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: A retrospective cohort study.J Perinatol 2017;37:1124-9.
  • 26. Povroznik JM, Engler-Chiurazzi, Nanavati T, Pergami P. Absolute lymphocyte and neutrophil counts in neonatal ischemic brain injury. SAGE Open Med 2018;6:2050312117752613.

Evaluation of Neonatal Abstinence Syndrome (NAS) Frequency and Systemic Inflammatory Response in NAS

Year 2019, Volume: 13 Issue: 3, 171 - 176, 24.05.2019

Cüneyt Tayman

https://doi.org/10.12956/tjpd.2018.357
Cited By: 2

Abstract

References

  • 1. Kocherlakota P. Neonatal Abstinence Syndrome. Pediatrics 2014;134:e547–61.
  • 2. Tolia VN, Patrick SW, Bennett MM. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med 2015; 372:2118-26.
  • 3. Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: A new standard. J Perinatol 2008; 28:597-603.
  • 4. WHO. Guidelines for identification and management of substance use and substance use disorders in pregnancy World Health Organization. 2014:224.
  • 5. Weaver MF. Perinatal addiction. In: Graham AW, Shultz TK (eds), Principles of Addiction Medicine, 3rd ed. American Society of Addiction Medicine, 2003:1231.
  • 6. Wong S, Ordean A, Kahan M; Maternal Fetal Medicine Committee; Family Physicians Advisory Committee; Medico-Legal Committee; Ad Hoc Reviewers; Special Contributors. Substance use in pregnancy. J Obstet Gynaecol Can 2011;33:367-84.
  • 7. Zahorec R. Ratio of neutrophil to lymphocyte counts- Rapid and simple parameter of systemic inflammation and stress n critically ill. Bratisl Lek Listy 2001; 102:5-14.
  • 8. Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A. C-Reactive Protein and substance use disorders in adolescence and early adulthood: A prospective analysis. Drug Alcohol Depend 2013;133:712–7.
  • 9. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: Assessment and management. Addict Dis 1975;2:141–58.
  • 10. Hudak ML, Tan RC. Neonatal drug withdrawal. Pediatrics 2012;129:540-60.
  • 11. Bagley SM, Wachman EM, Holland E, Brogly SB. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract 2014;9:19.
  • 12. Tetstall E, Liu AJ, An EI, Canalese J, Nanan R. Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: A rural and metropolitan comparison. Aust N Z J Obstet Gynaecol 2009;49: 279–84.
  • 13. Huybrechts KF, Bateman BT, Desai RJ, Hernandez-Diaz S, Rough K, Mogun H, et al. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: Cohort study. BMJ 2017;358:3326.
  • 14. Hall ES, Wexelblatt SL, Crowley M, Grow JL, Jasin LR, Klebanoff MA, et al. OCHNAS Consortium. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome. Pediatrics 2014;134:e527-34.
  • 15. ACOG Committee on Practice Bulletins; Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008;111:1001–20.
  • 16. Shainker SA, Saia K, Lee-Parritz A. Opioid addiction in pregnancy. Obstet Gynecol Surv 2012;67:817–25.
  • 17. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn and young child. Int J Addict 1993;28:1341-91.
  • 18. Grossman MR, Berkwitt AK, Osborn RR. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics 2017;139:e20163360.
  • 19. Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D, Lindow SW. Neonatal outcome following maternal opiate use in late pregnancy. Int J Obstet Gynaecol 2001;74:241-6.
  • 20. Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol 2015;15:146.
  • 21. Yazar FM, Bakacak M, Emre A, Urfalıoglu A, Serin S, Cengiz E, et al. Predictive role of neutrophil-to-lymphocyte and plateletto- lymphocyte ratios for diagnosis of acute appendicitis during pregnancy. Kaohsiung J Med Sci 2015;31:591-6.
  • 22. Demir AK, Demirtas A, Kaya SU, Tastan I, Butun I, Sagcan M, et al. The relationship between the neutrophilelymphocyte ratio and disease activity in patients with ulcerative colitis. Kaohsiung J Med Sci 2015;31:585-90.
  • 23. Özkan N, Sonmez MB, Durmus P Tas, Gorgulu Y, Cınar R Kose, Vardar ME. Elevated neutrophil lymphocyte ratio in patients with substance use disorders. European Psychiatry 2017;41:S872-S873.
  • 24. Catal F, Tayman C, Tonbul A, Akça H, Kara S, Tatli MM, et al. Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants. Clin Lab 2014;60:1193-200.
  • 25. Witt CE, Rudd KE, Bhatraju P, Rivara FP, Hawes SE, Weiss NS. Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: A retrospective cohort study.J Perinatol 2017;37:1124-9.
  • 26. Povroznik JM, Engler-Chiurazzi, Nanavati T, Pergami P. Absolute lymphocyte and neutrophil counts in neonatal ischemic brain injury. SAGE Open Med 2018;6:2050312117752613.
There are 26 citations in total.

Details

Primary Language Turkish
Subjects ​Internal Diseases
Journal Section ORIGINAL ARTICLES
Authors

Cüneyt Tayman

Publication Date May 24, 2019
Submission Date December 25, 2017
Published in Issue Year 2019 Volume: 13 Issue: 3

Cite

Vancouver Tayman C. Neonatal Yoksunluk Sendromu (NYS) Sıklığı ve NYS’de Sistemik İnflamatuvar Yanıtın Değerlendirilmesi. Türkiye Çocuk Hast Derg. 2019;13(3):171-6.

Cited By

Prenatal Substance Abuse: a 1-Year Single-Center Experience at a Tertiary Neonatal Intensive Care Unit
Turkish Journal of Pediatric Disease
https://doi.org/10.12956/tchd.1284603
Madde Bağımlısı Anne Bebeklerinin Klinik ve Laboratuvar Özellikleri: Tek Merkez Deneyimi
Bağımlılık Dergisi
https://doi.org/10.51982/bagimli.1141958


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.